Drug discovery

reMYND's Lead Alzheimer drug demonstrates neuroprotection
15-11-2008
reMYND's Lead Alzheimer drug demonstrates neuroprotection in 2 transgenic animal models of TAU and Amyloid bèta pathology.
Read more
Lead product for treating Parkinson's Disease demonstrates efficacy
15-03-2008
Lead product for treating Parkinson's Disease demonstrates efficacy in 3 different animal models of Parkinson's Disease.
Read more
reMYND's Parkinson's disease drug discovery program reaches breakthrough
26-03-2007
reMYND nv has reached a breakthrough in its drug discovery program aimed at identifying disease-modifying drugs for the treatment of Parkinson's disease.
Read more